Program
Pregabalin
Also written as “pregabalin”, “pregabalin (Lyrica)” and “Pregabalin ER”.
Its studies are mostly in Neuralgia · Fibromyalgia · Diabetic Neuropathies · Epilepsies, Partial · Neuralgia, Postherpetic, led by 18 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Viatris | 940 open or running | phase 4since Aug 31, 2005 | Aug 30, 2005 | none ahead |
| Pfizer | 180 open or running | phase 4since Apr 16, 2012 | Aug 30, 2005 | none ahead |
| Yuhan | 80 open or running | phase 4since Apr 13, 2021 | Aug 17, 2011 | none ahead |
| GL Pharm Tech | 40 open or running | phase 1since Jul 4, 2012 | Jul 4, 2012 | none ahead |
| Laboratorios Silanes S.A. de C.V. | 30 open or running | phase 3since Apr 4, 2022 | Apr 4, 2022 | none ahead |
| Merck | 20 open or running | phase 1since Dec 7, 2007 | Dec 7, 2007 | none ahead |
| Nevakar | 20 open or running | phase 2since Jul 27, 2020 | Jan 29, 2020 | none ahead |
| analgesic-solutions | 10 open or running | phase 4since Dec 13, 2012 | Dec 13, 2012 | none ahead |
| depomed | 10 open or running | phase 4since Jun 5, 2017 | Jun 5, 2017 | none ahead |
| Dexa Medica Group | 10 open or running | no phasesince Sep 4, 2014 | Sep 4, 2014 | none ahead |
| Egymedicalpedia | 10 open or running | early phase 1since Apr 8, 2023 | Apr 8, 2023 | none ahead |
| Hypera Pharma | 11 open or running | phase 3since Jun 18, 2026 | Jun 18, 2026 | Jun 1, 2027phase 3 · NCT07712913 |
| Jiangsu HengRui Medicine | 10 open or running | phase 3since Jul 8, 2015 | Jul 8, 2015 | none ahead |
| krka | 10 open or running | phase 4since Jan 24, 2020 | Jan 24, 2020 | none ahead |
| Latigo Biotherapeutics | 10 open or running | early phase 1since Sep 13, 2024 | Sep 13, 2024 | none ahead |
| unimed-pharmaceuticals | 10 open or running | phase 1since Mar 3, 2013 | Mar 3, 2013 | none ahead |
| yung-shin-pharm-ind-co-ltd | 10 open or running | phase 4since Oct 8, 2018 | Oct 8, 2018 | none ahead |
| yungjin-pharm-co-ltd | 10 open or running | phase 1since Aug 22, 2017 | Aug 22, 2017 | none ahead |
Also a collaborator on its studies: nevakar-injectables-inc, Boehringer Ingelheim and Astellas Pharma.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 46 studies since Nov 23, 2009.
- Oct 8, 2018yung-shin-pharm-ind-co-ltd's first study: phase 4 study in FibromyalgiaNew to yung-shin-pharm-ind-co-ltdyung-shin-pharm-ind-co-ltd · NCT03712475 · 28 enrolled · Taiwan
- Jan 24, 2020krka's first study: phase 4 study in Painful Diabetic Peripheral NeuropathyNew to krkakrka · NCT04246619 · 254 enrolled · Croatia, North Macedonia, Poland and more
- Jan 29, 2020Nevakar's first study: phase 1 study in Pain, PostoperativeNew to NevakarNevakar · NCT04265456 · 63 enrolled · United States
- Jul 27, 2020Phase 2 study in Pain, PostoperativeNevakar · NCT04495283 · 87 enrolled · United States
- Apr 13, 2021Phase 4 study in Diabetic Peripheral NeuropathyYuhan · NCT04846673 · 151 enrolled · Korea, Republic of
- Jul 27, 2021Phase 1 study in Healthy VolunteerYuhan · NCT05012436 · 16 enrolled · Korea, Republic of
- Sep 13, 2021Phase 4 study in Abuse PotentialViatris · NCT05053126 · 60 enrolled · United States
- Apr 4, 2022Laboratorios Silanes S.A. de C.V.'s first study: phase 3 study in NeuralgiaNew to Laboratorios Silanes S.A. de C.V.Laboratorios Silanes S.A. de C.V. · NCT05324059 · 110 enrolled · Mexico
- May 19, 2022Phase 1 study in Acute PainLaboratorios Silanes S.A. de C.V. · NCT05389150 · 30 enrolled · Mexico
- Nov 14, 2022Phase 4 study in NeuralgiaYuhan · NCT05624853 · 130 enrolled · Korea, Republic of
- Apr 8, 2023Egymedicalpedia's first study: early phase 1 study in Endoscopic Sinus SurgeryNew to EgymedicalpediaEgymedicalpedia · NCT05829148 · 120 enrolled · Egypt
- Jun 26, 2024Phase 3 study in Low Back PainLaboratorios Silanes S.A. de C.V. · NCT06516094 · 192 enrolled · Mexico
- Sep 13, 2024Latigo Biotherapeutics's first study: early phase 1 study in Pain DetectionNew to Latigo BiotherapeuticsLatigo Biotherapeutics · NCT06600607 · 20 enrolled · New Zealand
- Jun 18, 2026Hypera Pharma's first study: phase 3 study in Diabetic NeuropathiesNew to Hypera PharmaHypera Pharma · NCT07712913 · 348 planned · Brazil
Ahead
- Jun 1, 2027Primary completion: phase 3 study in Diabetic NeuropathiesHypera Pharma · NCT07712913
TargetBeta
“Voltage-gated calcium channel modulator”ChEMBL 37, by rule
Other programs on the same 26 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Gabapentinrule | Viatris | phase 4 | 49 |
Studies
The newest 60 of 142 led by companies developing it. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07712913Diabetic Neuropathies · Brazil | 3 | Recruiting | Hypera Pharma | Jun 1, 2027 | 348 |
| NCT06600607Pain Detection · New Zealand | Early 1 | Completed | Latigo Biotherapeutics | Oct 27, 2024 | 20 |
| NCT06516094Low Back Pain · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Jan 1, 2025 | 192 |
| NCT05829148Endoscopic Sinus Surgery · Egypt | Early 1 | UNKNOWN | Egymedicalpedia | Nov 1, 2024 | 120 |
| NCT05624853Neuralgia · Korea, Republic of | 4 | Completed | Yuhan | Dec 20, 2022 | 130 |
| NCT05389150Acute Pain · Mexico | 1 | Completed | Laboratorios Silanes S.A. de C.V. | Feb 5, 2019 | 30 |
| NCT05324059Neuralgia · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Apr 18, 2023 | 110 |
| NCT05053126Abuse Potential · United States | 4 | Completed | Viatris | Apr 1, 2022 | 60 |
| NCT05012436Healthy Volunteer · Korea, Republic of | 1 | Completed | Yuhan | May 10, 2022 | 16 |
| NCT04846673Diabetic Peripheral Neuropathy · Korea, Republic of | 4 | Completed | Yuhan | Nov 30, 2022 | 151 |
| NCT04495283Pain, Postoperative · United States | 2 | Completed | Nevakar | Nov 12, 2020 | 87 |
| NCT04265456Pain, Postoperative · United States | 1 | Completed | Nevakar | Jun 15, 2020 | 63 |
| NCT04246619Painful Diabetic Peripheral Neuropathy · Croatia, North Macedonia, Poland and more | 4 | Terminated | krka | Dec 21, 2021 | 254 |
| NCT03712475Fibromyalgia · Taiwan | 4 | Completed | yung-shin-pharm-ind-co-ltd | Sep 16, 2018 | 28 |
| NCT03261427Healthy · Korea, Republic of | 1 | Completed | yungjin-pharm-co-ltd | Oct 11, 2017 | 17 |
| NCT03179345Healthy | 4 | Completed | depomed | Nov 20, 2015 | 32 |
| NCT03191136Peripheral Neuropathic Pain · Korea, Republic of | 1 | Completed | Yuhan | Jun 27, 2017 | 24 |
| NCT02985216Peripheral Neuropathic Pain · Korea, Republic of | 3 | Completed | Yuhan | Apr 27, 2018 | 371 |
| NCT02783183Peripheral Nueropathy Pain | 1 | Completed | Yuhan | Aug 2016 | 32 |
| NCT02783638Peripheral Neuropathy Pain · Korea, Republic of | 1 | Completed | Yuhan | Apr 2016 | 64 |
| NCT02725112Healthy · United States | 1 | Completed | Viatris | May 22, 2016 | 25 |
| NCT02868801Neuralgia, Postherpetic · China | 3 | UNKNOWN | Jiangsu HengRui Medicine | Jun 2017 | 280 |
| NCT02327000Healthy | 1 | Completed | GL Pharm Tech | Oct 2014 | 40 |
| NCT02326987Healthy | 1 | Completed | GL Pharm Tech | Nov 2013 | 30 |
| NCT02233777Healthy · Indonesia | – | Completed | Dexa Medica Group | Jun 2014 | 20 |
| NCT02215252Diabetic Neuropathies · United States | 2 | Completed | Pfizer | Jul 15, 2015 | 141 |
| NCT02072824Epilepsy · United States, Belarus, Belgium and more | 3 | Completed | Viatris | Mar 13, 2018 | 175 |
| NCT01838044Chronic Low Back Pain With a Neuropathic Component · Brazil, Chile, Colombia and more | 4 | Terminated | Viatris | May 2015 | 180 |
| NCT01808300Healthy | 1 | Completed | unimed-pharmaceuticals | Jul 2013 | 42 |
| NCT01770964Diabetes Mellitus · United States | 4 | UNKNOWN | analgesic-solutions | Jul 2013 | 90 |
| NCT01747915Seizures · United States, Austria, Belarus and more | 3 | Completed | Viatris | Feb 20, 2019 | 219 |
| NCT01727791Breast Feeding · Belgium | 4 | Completed | Viatris | Aug 2013 | 10 |
| NCT01701362Neuralgia · United States, Bulgaria, Canada and more | 3 | Completed | Viatris | Aug 2015 | 542 |
| NCT01638273Healthy · Korea, Republic of | 1 | Completed | GL Pharm Tech | Jul 2014 | 24 |
| NCT01635751Healthy · Korea, Republic of | 1 | Completed | GL Pharm Tech | Nov 2012 | 30 |
| NCT01603394Neuralgia, Postherpetic · United States, Austria, Germany and more | 4 | Terminated | Pfizer | Jun 2013 | 9 |
| NCT01474772Diabetic Peripheral Neuropathy · United States, Czechia, South Africa and more | 3 | Completed | Viatris | Jul 2013 | 217 |
| NCT01463306Epilepsy · United States, Belarus, Belgium and more | 3 | Completed | Viatris | Aug 22, 2019 | 605 |
| NCT01455428Neuralgia, Postherpetic · China | 4 | Completed | Viatris | Jan 2014 | 223 |
| NCT01455415Painful Diabetic Peripheral Neuropathy · United States, Czechia, Italy and more | 3 | Completed | Viatris | Nov 2013 | 306 |
| NCT01432236Fibromyalgia · United States, Canada, Italy and more | 3 | Completed | Viatris | Jul 2013 | 197 |
| NCT01420913Healthy · Korea, Republic of | 1 | Completed | Yuhan | Aug 2011 | 28 |
| NCT01387607Fibromyalgia · China | 3 | Completed | Viatris | Oct 31, 2016 | 343 |
| NCT01332149Diabetic Neuropathies · China | 3 | Completed | Viatris | Apr 2014 | 626 |
| NCT01298466Low Back Pain | 4 | Withdrawn | Viatris | Feb 2013 | 0 |
| NCT01271933Fibromyalgia · United States, Canada, India and more | 3 | Completed | Viatris | Jul 2012 | 441 |
| NCT01270828Neuralgia, Postherpetic · United States, Bulgaria, Colombia and more | 3 | Completed | Viatris | Sep 2014 | 806 |
| NCT01262677Seizures · United States, Argentina, Bosnia and Herzegovina and more | 3 | Completed | Viatris | Jul 31, 2012 | 325 |
| NCT01257516Healthy · Belgium | 1 | Completed | Viatris | Mar 2011 | 18 |
| NCT01220219Healthy · Belgium | 1 | Completed | Viatris | Jan 2011 | 24 |
| NCT01202435Healthy · Belgium | 1 | Completed | Viatris | Nov 2010 | 18 |
| NCT01202422Healthy · Belgium | 1 | Completed | Viatris | Nov 2010 | 24 |
| NCT01202227Spinal Cord Diseases · Japan | 3 | Completed | Viatris | Mar 2012 | 104 |
| NCT01145417Neuralgia · United States, Colombia, India and more | 3 | Terminated | Viatris | May 2012 | 217 |
| NCT01117766Neuralgia · Austria, Belgium, France and more | – | Completed | Pfizer | Sep 2009 | 31 |
| NCT01080612Healthy · United States | 1 | Completed | Viatris | Jun 2010 | 24 |
| NCT01061372Restless Legs Syndrome | 3 | Withdrawn | Viatris | Aug 2011 | 0 |
| NCT01057693Diabetic Neuropathies · United States, Canada, Puerto Rico and more | 3 | Completed | Viatris | Jan 30, 2012 | 633 |
| NCT01049217Pain · United States, Colombia, Dominican Republic and more | 3 | Terminated | Viatris | May 2012 | 377 |
| NCT01020526Fibromyalgia · United States, Czechia, India | 4 | Completed | Viatris | Jun 2015 | 63 |
How it is read
Names in the registry
- “Pregabalin”, 80 entries
- “pregabalin”, 43 entries
- “pregabalin (Lyrica)”, 7 entries
- “Pregabalin ER”, 6 entries
- “Pregabalin 150mg”, 5 entries
Codes read as this program: YHD1119.
Conditions, from the studies’ own filings
- Neuralgia, 18 studies
- Fibromyalgia, 16 studies
- Diabetic Neuropathies, 14 studies
- Epilepsies, Partial, 12 studies
- Neuralgia, Postherpetic, 10 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.